Advertisement

Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men

  • R. Kouvelioti
  • P. LeBlanc
  • B. Falk
  • W. E. Ward
  • A. R. Josse
  • P. KlentrouEmail author
Original Research
  • 44 Downloads

Abstract

This study compared sclerostin’s response to impact versus no-impact high-intensity interval exercise in young men and examined the association between exercise-induced changes in sclerostin and markers of bone turnover and oxidative stress. Twenty healthy men (22.3 ± 2.3 years) performed two high-intensity interval exercise trials (crossover design); running on treadmill and cycling on cycle ergometer. Trials consisted of eight 1 min running or cycling intervals at ≥ 90% of maximal heart rate, separated by 1 min passive recovery intervals. Blood samples were collected at rest (pre-exercise), and 5 min, 1 h, 24 h, and 48 h following each trial. Serum levels of sclerostin, cross-linked telopeptide of type I collagen (CTXI), procollagen type I amino-terminal propeptide (PINP), thiobarbituric acid reactive substances (TBARS), and protein carbonyls (PC) were measured. There was no significant time or exercise mode effect for PINP and PC. A significant time effect was found for sclerostin, CTXI, and TBARS with no significant exercise mode effect and no significant time-by-mode interaction. Sclerostin increased from pre- to 5 min post-exercise (47%, p < 0.05) and returned to baseline within 1 h following the exercise. CTXI increased from pre- to 5 min post-exercise (28%, p < 0.05), then gradually returned to baseline by 48 h. TBARS did not increase significantly from pre- to 5 min post-exercise but significantly decreased from 5 min to 48 h post-exercise. There were no significant correlations between exercise-induced changes in sclerostin and any other marker. In young men, sclerostin’s response to high-intensity interval exercise is independent of impact and is not related to changes in bone turnover and oxidative stress markers.

Keywords

Exercise Sclerostin Bone turnover Oxidative stress 

Notes

Acknowledgements

This study was funded by the National Sciences and Engineering Research Council of Canada (NSERC) grant to P. Klentrou (grant # 2015-04424). R. Kouvelioti holds an Ontario Trillium Scholarship. W. Ward holds a Canada Research Chair in Bone and Muscle Development. The authors would like to thank the participants for participating in this study, all volunteers for their assistance in different parts of the study (D. Brown, R. Sweeney, M. Nasato, A. Theocharidis, S. Pilakka, D. Szkaradek), the phlebotomists (especially C. Watt), and lab coordinators (R. Dotan, J. Gabrie) for their guidance.

Author Contributions

RK designed the study, completed all data collection, and prepared the first draft of the paper. PL contributed to the analysis of blood samples. BF, WEW, and ARJ contributed to the experimental design and the interpretation of the data. PK was the supervisor of the research and contributed to the experimental design, data analysis, and interpretation of the data. She is the guarantor. All authors revised the paper critically for intellectual content and approved the final version. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.

Compliance with Ethical Standards

Conflict of interest

R. Kouvelioti, P. LeBlanc, B. Falk, W.E. Ward, A.R. Josse and P. Klentrou have no conflict of interest to declare.

Human and Animal Rights and Informed Consent

The study was conducted in accordance with the Declaration of Helsinki and received ethics approval from our institutional Research Ethics Board (File # 16-016). All participants agreed to participate in this study by signing a consent form.

References

  1. 1.
    Kohrt WM, Barry DW, Schwartz RS (2009) Muscle forces or gravity: what predominates mechanical loading on bone? Med Sci Sports Exerc 41:2050–2055.  https://doi.org/10.1249/MSS.0b013e3181a8c717 CrossRefGoogle Scholar
  2. 2.
    Banfi G, Lombardi G, Colombini A, Lippi G (2010) Bone metabolism markers in sports medicine. Sport Med 40:697–714.  https://doi.org/10.2165/11533090-000000000-00000 CrossRefGoogle Scholar
  3. 3.
    Mezil YA, Allison D, Kish K, Ditor D, Ward WE, Tsiani E, Klentrou P (2015) Response of bone turnover markers and cytokines to high-intensity low-impact exercise. Med Sci Sports Exerc 47:1495–1502.  https://doi.org/10.1249/MSS.0000000000000555 CrossRefGoogle Scholar
  4. 4.
    Kouvelioti R, Kurgan N, Falk B, Ward WE, Josse AR, Klentrou P (2018) Response of sclerostin and bone turnover markers to high-intensity interval exercise in young women: does impact matter? BioMed Res Int 2018:8CrossRefGoogle Scholar
  5. 5.
    Sapir-Koren R, Livshits G (2014) Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles? Osteoporos Int 25:2685–2700.  https://doi.org/10.1007/s00198-014-2808-0 CrossRefGoogle Scholar
  6. 6.
    Moester MJC, Papapoulos SE, Löwik CWGM, van Bezooijen RL (2010) Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 87:99–107.  https://doi.org/10.1007/s00223-010-9372-1 CrossRefGoogle Scholar
  7. 7.
    Spatz J, Wein M, Gooi J, Qu Y, Garr J, Liu S, Barry K, Uda Y, Lai F, Dedic C (2015) The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro. J Biol Chem 290:16744–16758CrossRefGoogle Scholar
  8. 8.
    Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin. J Biol Chem 283:5866–5875.  https://doi.org/10.1074/jbc.M705092200 CrossRefGoogle Scholar
  9. 9.
    Falk B, Haddad F, Klentrou P, Ward W, Kish K, Mezil Y, Radom-Aizik S (2016) Differential sclerostin and parathyroid hormone response to exercise in boys and men. Osteoporos Int 27:1245–1249.  https://doi.org/10.1007/s00198-015-3310-z CrossRefGoogle Scholar
  10. 10.
    Pickering M-E, Simon M, Sornay-Rendu E, Chikh K, Carlier M-C, Raby A-L, Szulc P, Confavreux CB (2017) Serum sclerostin increases after acute physical activity. Calcif Tissue Int 101:170–173.  https://doi.org/10.1007/s00223-017-0272-5 CrossRefGoogle Scholar
  11. 11.
    Gombos GC, Bajsz V, Pék E, Schmidt B, Sió E, Molics B, Betlehem J (2016) Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass. BMC Musculoskelet Disord 17:254.  https://doi.org/10.1186/s12891-016-1109-5 CrossRefGoogle Scholar
  12. 12.
    Kerschan-Schindl K, Thalmann MM, Weiss E, Tsironi M, Föger-Samwald U, Meinhart J, Skenderi K, Pietschmann P (2015) Changes in serum levels of myokines and Wnt-antagonists after an ultramarathon race. PLoS ONE 10:e0132478.  https://doi.org/10.1371/journal.pone.0132478 CrossRefGoogle Scholar
  13. 13.
    Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, Liu G, Bilezikian JP (2013) Circulating sclerostin levels and markers of bone turnover in chinese-american and white women. J Clin Endocrinol Metab 98:4736–4743.  https://doi.org/10.1210/jc.2013-2106 CrossRefGoogle Scholar
  14. 14.
    Durosier C, van Lierop A, Ferrari S, Chevalley T, Papapoulos S, Rizzoli R (2013) Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women. J Clin Endocrinol Metab 98:3873–3883.  https://doi.org/10.1210/jc.2013-2113 CrossRefGoogle Scholar
  15. 15.
    Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248–2253.  https://doi.org/10.1210/jc.2010-0067 CrossRefGoogle Scholar
  16. 16.
    Kawamura T, Muraoka I (2018) Exercise-induced oxidative stress and the effects of antioxidant intake from a physiological viewpoint. Antioxidants 7:119.  https://doi.org/10.3390/antiox7090119 CrossRefGoogle Scholar
  17. 17.
    Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y (2009) Oxidative stress in bone remodelling and disease. Trends Mol Med 15:468–477.  https://doi.org/10.1016/j.molmed.2009.08.004 CrossRefGoogle Scholar
  18. 18.
    Manolagas SC, Almeida M (2007) Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 21:2605–2614.  https://doi.org/10.1210/me.2007-0259 CrossRefGoogle Scholar
  19. 19.
    Kang J, Boonanantanasarn K, Baek K, Woo KM, Ryoo H-M, Baek J h, Kim G-S (2015) Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner. J Periodontal Implant Sci 45:101.  https://doi.org/10.5051/jpis.2015.45.3.101 CrossRefGoogle Scholar
  20. 20.
    Fisher-Wellman K, Bloomer RJ (2009) Acute exercise and oxidative stress: a 30 year history. Dyn Med 8:1.  https://doi.org/10.1186/1476-5918-8-1 CrossRefGoogle Scholar
  21. 21.
    Bloomer RJ, Goldfarb AH (2004) Anaerobic exercise and oxidative stress: a review. Can J Appl Physiol 29:245–263.  https://doi.org/10.1139/h04-017 CrossRefGoogle Scholar
  22. 22.
    Steinberg JG, Ba A, Brégeon F, Delliaux S, Jammes Y (2007) Cytokine and oxidative responses to maximal cycling exercise in sedentary subjects. Med Sci Sports Exerc 39:964–968.  https://doi.org/10.1097/mss.0b013e3180398f4b CrossRefGoogle Scholar
  23. 23.
    Bloomer R, Goldfarb A, Wideman L, McKenzie M, Consitt L (2005) Effects of acute aerobic and anaerobic exercise on blood markers of oxidative stress. J Strength Cond Res 19:276.  https://doi.org/10.1519/14823.1 Google Scholar
  24. 24.
    Borg GA (1973) Perceived exertion: a note on “history” and methods. Med Sci Sports 5:90–93Google Scholar
  25. 25.
    Levine RL, Williams JA, Stadtman EP, Shacter E (1994) [37] Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346–357.  https://doi.org/10.1016/S0076-6879(94)33040-9 CrossRefGoogle Scholar
  26. 26.
    Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363CrossRefGoogle Scholar
  27. 27.
    Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.  https://doi.org/10.1016/0003-2697(76)90527-3 CrossRefGoogle Scholar
  28. 28.
    Kei S (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90:37–43.  https://doi.org/10.1016/0009-8981(78)90081-5 CrossRefGoogle Scholar
  29. 29.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.  https://doi.org/10.1016/0003-2697(79)90738-3 CrossRefGoogle Scholar
  30. 30.
    Kargotich S, Goodman C, Keast D, Morton AR (1998) The influence of exercise-induced plasma volume changes on the interpretation of biochemical parameters used for monitoring exercise, training and sport. Sport Med 26:101–117.  https://doi.org/10.2165/00007256-199826020-00004 CrossRefGoogle Scholar
  31. 31.
    Weinstein Y, Bediz C, Dotan R, Falk B (1998) Reliability of peak-lactate, heart rate, and plasma volume following the Wingate test. Med Sci Sports Exerc 30:1456–1460Google Scholar
  32. 32.
    Van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 32:712–713.  https://doi.org/10.1152/jappl.1972.32.5.712 CrossRefGoogle Scholar
  33. 33.
    Rogers RS, Dawson AW, Wang Z, Thyfault JP, Hinton PS (2011) Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics. J Appl Physiol 111:1353–1360.  https://doi.org/10.1152/japplphysiol.00333.2011 CrossRefGoogle Scholar
  34. 34.
    van Beaumont W, Strand JC, Petrofsky JS, Hipskind SG, Greenleaf JE (1973) Changes in total plasma content of electrolytes and proteins with maximal exercise. J Appl Physiol 34:102–106.  https://doi.org/10.1152/jappl.1973.34.1.102 CrossRefGoogle Scholar
  35. 35.
    de Oliveira Teixeira A, Franco OS, Borges MM, Martins CN, Guerreiro LF, da Rosa CE, da Silva Paulitsch F, Perez W, da Silva AM, Signori LU (2014) The importance of adjustments for changes in plasma volume in the interpretation of hematological and inflammatory responses after resistance exercise. J Exerc Physiol 17:72–83Google Scholar
  36. 36.
    Kirmani S, Amin S, McCready LK, Atkinson EJ, Melton LJ, Müller R, Khosla S (2012) Sclerostin levels during growth in children. Osteoporos Int 23:1123–1130.  https://doi.org/10.1007/s00198-011-1669-z CrossRefGoogle Scholar
  37. 37.
    Mödder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, Melton LJ, Khosla S (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26:373–379.  https://doi.org/10.1002/jbmr.217 CrossRefGoogle Scholar
  38. 38.
    Dekker J, Nelson K, Kurgan N, Falk B, Josse A, Klentrou P (2017) Wnt signaling–related osteokines and transforming growth factors before and after a single bout of plyometric exercise in child and adolescent females. Pediatr Exerc Sci 29:504–512.  https://doi.org/10.1123/pes.2017-0042 CrossRefGoogle Scholar
  39. 39.
    Klentrou P, Angrish K, Awadia N, Kurgan N, Kouvelioti R, Falk B (2018) Wnt signaling–related osteokines at rest and following plyometric exercise in prepubertal and early pubertal boys and girls. Pediatr Exerc Sci.  https://doi.org/10.1123/pes.2017-0259 Google Scholar
  40. 40.
    Heinonen I, Kemppainen J, Kaskinoro K, Langberg H, Knuuti J, Boushel R, Kjaer M, Kalliokoski KK (2013) Bone blood flow and metabolism in humans: effect of muscular exercise and other physiological perturbations. J Bone Miner Res 28:1068–1074.  https://doi.org/10.1002/jbmr.1833 CrossRefGoogle Scholar
  41. 41.
    Farquhar B, Kenney W (1997) Anti-inflamatory drugs, kidney function, and exercise. Sport Sci Exch 11:1–6Google Scholar
  42. 42.
    Fairfield H, Rosen CJ, Reagan MR (2017) Connecting bone and fat: the potential role for sclerostin. Curr Mol Biol Rep 3:114–121.  https://doi.org/10.1007/s40610-017-0057-7 CrossRefGoogle Scholar
  43. 43.
    Fulzele K, Lai F, Dedic C, Saini V, Uda Y, Shi C, Tuck P, Aronson JL, Liu X, Spatz JM, Wein MN, Divieti Pajevic P (2017) Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots. J Bone Miner Res 32:373–384.  https://doi.org/10.1002/jbmr.3001 CrossRefGoogle Scholar
  44. 44.
    Morgan AL, Weiss J, Kelley ET (2015) Bone turnover response to acute exercise with varying impact levels: a preliminary investigation. Int J Exerc Sci 8:154–163Google Scholar
  45. 45.
    Ardawi M-SM, Rouzi AA, Qari MH (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. J Clin Endocrinol Metab 97:3691–3699.  https://doi.org/10.1210/jc.2011-3361 CrossRefGoogle Scholar
  46. 46.
    Grasso D, Corsetti R, Lanteri P, Di Bernardo C, Colombini A, Graziani R, Banfi G, Lombardi G (2015) Bone-muscle unit activity, salivary steroid hormones profile, and physical effort over a 3-week stage race. Scand J Med Sci Sports 25:70–80.  https://doi.org/10.1111/sms.12147 CrossRefGoogle Scholar
  47. 47.
    Gaeini AA, Rahnama N, Hamedinia MR (2006) Effects of vitamin E supplementation on oxidative stress at rest and after exercise to exhaustion in athletic students. J Sports Med Phys Fitness 46:458–461Google Scholar
  48. 48.
    Bloomer R, Davis P, Consitt L, Wideman L (2007) Plasma protein carbonyl response to increasing exercise duration in aerobically trained men and women. Int J Sports Med 28:21–25.  https://doi.org/10.1055/s-2006-924140 CrossRefGoogle Scholar
  49. 49.
    Chevion S, Moran DS, Heled Y, Shani Y, Regev G, Abbou B, Berenshtein E, Stadtman ER, Epstein Y (2003) Plasma antioxidant status and cell injury after severe physical exercise. Proc Natl Acad Sci USA 100:5119–5123.  https://doi.org/10.1073/pnas.0831097100 CrossRefGoogle Scholar
  50. 50.
    Urso ML, Clarkson PM (2003) Oxidative stress, exercise, and antioxidant supplementation. Toxicology 189:41–54CrossRefGoogle Scholar
  51. 51.
    Veskoukis AS, Nikolaidis MG, Kyparos A, Kouretas D (2009) Blood reflects tissue oxidative stress depending on biomarker and tissue studied. Free Radic Biol Med 47:1371–1374.  https://doi.org/10.1016/J.FREERADBIOMED.2009.07.014 CrossRefGoogle Scholar
  52. 52.
    Parker L, Trewin A, Levinger I, Shaw CS, Stepto NK (2018) Exercise-intensity dependent alterations in plasma redox status do not reflect skeletal muscle redox-sensitive protein signaling. J Sci Med Sport 21:416–421.  https://doi.org/10.1016/J.JSAMS.2017.06.017 CrossRefGoogle Scholar
  53. 53.
    Ashton T, Rowlands CC, Jones E, Young IS, Jackson SK, Davies B, Peters JR (1998) Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise. Eur J Appl Physiol 77:498–502.  https://doi.org/10.1007/s004210050366 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Kinesiology, Faculty of Applied Health SciencesBrock UniversitySt. CatharinesCanada
  2. 2.Department of Health ScienceBrock UniversitySt. CatharinesCanada
  3. 3.Centre for Bone and Muscle Health, Faculty of Applied Health SciencesBrock UniversitySt. CatharinesCanada

Personalised recommendations